D E Williams
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Toxicology top 5%
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- David M. Stresser (4 shared papers)G.S. Bailey (4 shared papers)Daniel M. Ziegler (2 shared papers)John R. Cashman (2 shared papers)Donald R. Buhler (3 shared papers)Donald A. Griffin (1 shared paper)Ronald N. Hines (1 shared paper)R.M. Philpot (1 shared paper)
- Journals
- Drug Metabolism and Disposition (4 papers)Analytical Biochemistry (1 paper)Toxicology and Applied Pharmacology (1 paper)Molecular Pharmacology (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
D E Williams
16 papers receiving 630 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 190
- Toxicology 49
- Health, Toxicology and Mutagenesis 152
- Cancer Research 91
- Pollution 76
Countries citing papers authored by D E Williams
This map shows the geographic impact of D E Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Williams more than expected).
Fields of papers citing papers by D E Williams
This network shows the impact of papers produced by D E Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Williams. The network helps show where D E Williams may publish in the future.
Co-authors
The 25 scholars most cited alongside D E Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 107 | |
| 2 | 1994 | 95 | |
| 3 | 1994 | 83 | |
| 4 | 1995 | 79 | |
| 5 | 1994 | 64 | |
| 6 | 1990 | 51 | |
| 7 | 2001 | 42 | |
| 8 | 1991 | 38 | |
| 9 | Modulation of mycotoxin and nitrosamine carcinogenesis by indole-3-carbinol: quantitative analysis of inhibition versus promotion. | 1991 | 21 |
| 10 | 1984 | 19 | |
| 11 | 1985 | 15 | |
| 12 | 1995 | 14 | |
| 13 | 1990 | 12 | |
| 14 | Protective effects of recombinant human interleukin-1 alpha in doxorubicin-treated normal and tumor-bearing mice. | 1993 | 12 |
| 15 | Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). | 1992 | 10 |
| 16 | Characterization and regulation of an extrahepatic form of rabbit FAD-containing monooxygenase (FMO) | 1986 | 1 |
About D E Williams
D E Williams is a scholar working on Molecular Biology, Pharmacology, Oncology, Health, Toxicology and Mutagenesis and Computational Theory and Mathematics, having authored 16 papers that have together received 663 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Analytical Chemistry and Chromatography (2 papers), Computational Drug Discovery Methods (2 papers), Environmental Toxicology and Ecotoxicology (2 papers) and Mycotoxins in Agriculture and Food (2 papers). The work is most often cited by research in Pharmacology (190 citations), Toxicology (49 citations), Health, Toxicology and Mutagenesis (152 citations), Cancer Research (91 citations) and Pollution (76 citations). D E Williams has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include David M. Stresser, G.S. Bailey, Daniel M. Ziegler, John R. Cashman, Donald R. Buhler, Donald A. Griffin, Ronald N. Hines, R.M. Philpot, Tommy Andersson and Anders Goksøyr. Their work appears in journals such as Drug Metabolism and Disposition, Analytical Biochemistry, Toxicology and Applied Pharmacology, Molecular Pharmacology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.